http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2767891-C2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf0fe3555e21378ce17b8355235f4ccb
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-145
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-145
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-86
filingDate 2020-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2022-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_54a4081fe81998179980838dfa131f55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9d1811600aeac3b7c977db0314e65d65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb4436f086590750292c57f9527dfd42
publicationDate 2022-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2767891-C2
titleOfInvention Method of screening examination for detection of risk groups of developing hypercoagulation state in conditions of expeditionary work in the arctic
abstract FIELD: medicine.SUBSTANCE: disclosed is a screening method for detecting risk groups of developing a hypercoagulation state in conditions of expeditionary work in the Arctic. Venous blood is sampled from the expedition members, sailors and shift workers in the Arctic zone. Obtained blood samples are centrifuged at 3,000 rpm for 15 minutes. Automatic analyzer is used to determine the lag-phase time (tLag), the thrombin peak formation time (tPeak), the thrombin peak (Peak) and the endogenous thrombin potential (AUC). If the lag phase (tLag) is less than 7.8 minutes, the thrombin peak formation time (tPeak) is less than 16.7 minutes, the thrombin peak (Peak) is more than 153.7 nM, thrombin endogenous potential (AUC) of more than 1,735.9 nM of the person being tested is considered to be at risk of developing hypercoagulation in conditions of expeditionary work in Arctic.EFFECT: invention provides objectification of the analyzed feature of hypercoagulation syndrome, increased diagnostic significance of the method and simplified interpretation of results, based on which a judgment is made on the possibility of the presence of hypercoagulation syndrome in conditions of expeditionary work in the Arctic.1 cl, 2 dwg, 3 tbl, 5 ex
priorityDate 2020-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2660706-C1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP22775
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00734
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID27367
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP13726
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID66000
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID395837
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419533737
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ19AZ8
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID325881
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID395306
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID66000
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID250453
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID11905
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID373926
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP84122
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID280685
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID431577138
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP81070
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ03352
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID280686
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2147
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP01008
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54678486
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID43736
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID90470996
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID451158
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409206349
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID29251
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60606
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP18292
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ5R537
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP81050
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP32261
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID540261
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP19221
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID8458
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP32262
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID462
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID304917
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP41361
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID14061
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6224
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ5R5A3
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534242
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCAAC63054

Total number of triples: 62.